Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment

NCT03941639 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03941639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03941639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Terminated
Start date
September 1, 2019
Completion date
December 31, 2022
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer